New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
10:27 EDTBCRX, NNVC, HEB, TKMRMapp drug used to treat Ebola patients, CNN reports
A drug made by privately held Mapp Biopharmaceutical was used to treat the two Americans who contracted Ebola, CNN reports, citing a source familiar with details of the treatment. The experimental treatment called ZMapp had never been tried before in a human but had showed promise with monkeys, CNN adds. Shares of Tekmira (TKMR), NanoViricides (NNVC), BioCryst (BCRX) and Hemispherx (HEB) are moving higher in early trading after two Americans were flown home with Ebola. Reference Link
News For TKMR;NNVC;BCRX;HEB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
10:00 EDTBCRXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:01 EDTBCRXBioCryst upgraded to Neutral from Underperform at BofA/Merrill
Subscribe for More Information
07:06 EDTNNVCNanoViricides reports dramatic improvement of herpes symptoms in animal studies
Subscribe for More Information
06:36 EDTBCRXBioCryst upgraded to Neutral from Underperform at BofA/Merrill
Subscribe for More Information
April 10, 2015
09:16 EDTTKMROn The Fly: Pre-market Movers
UP AFTER EARNINGS: Quantum (QTM), up 22.2%. ALSO HIGHER: General Electric (GE), up 6.6% after announcing that it will sell most of GE Capital assets for approximately $26.5B... Horizon Pharma (HZNP), up 3.7% after receiving fast track designation for Actimmune... Tekmira Pharmaceuticals (TKMR), up 2.3% after FDA modifies partial clinical hold on Tekmira TKM-Ebola IND... Netflix (NFLX), up 2.9% after being upgraded to Buy from Neutral at Citigroup... Blackstone Mortgage Trust (BXMT), up 3.6% after acquiring $4.6B loan portfolio from GE Capital. LOWER: Citrix Systems (CTXS), down 5.8% after lowering first quarter guidance... Uniqure (QURE), down 2.4% after 3M share Secondary priced at $29.50... FIS (FIS), down 2.5% after lowering first quarter guidance... Golub Capital (GBDC), down 2.3% after 3.5M share Spot Secondary priced at $17.42.
08:33 EDTTKMRFDA modifies partial clinical hold on Tekmira TKM-Ebola IND
Subscribe for More Information
08:32 EDTTKMRFDA modifies partial clinical hold on Tekmira TKM-Ebola IND
08:31 EDTTKMRTekmira trading halted, pending news
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use